文献速递细菌感染、耐药与抗菌药物

非复杂性呼吸道感染停用不必要抗生素的疗效与安全性:基层医疗多中心随机临床试验

Efficacy and safety of discontinuing antibiotic treatment for uncomplicated respiratory tract infections when deemed unnecessary. A multicentre, randomized clinical trial in primary care.
PubMed 文献 · Clin Microbiol Infect · 2021-08-04

该多中心开放标签随机对照试验纳入467例已用抗生素不足3天且医生认为不再需要的非复杂性呼吸道感染成人,比较停用与继续抗生素策略。结果显示两组严重症状持续时间无显著差异,停用组抗生素使用显著减少,不良事件风险未显著增加,提示停用是安全的并大幅减少抗生素消耗。

要点

  • 停用不必要抗生素不延长严重症状持续时间。
  • 停用组抗生素使用比例显著低于继续组。
  • 停用未显著增加不良事件或后续就医需求。

核心结论

  • 对于医生认为不再需要的非复杂性呼吸道感染,停用抗生素是安全的,并显著减少抗生素消耗。

研究设计与样本

  • 多中心、开放标签、随机对照临床试验,2017至2020年在基层医疗中心开展,纳入467例成人患者,409例纳入有效分析。

主要发现

  • 停用组严重症状平均持续3.0(1.5)天,继续组为2.8(1.3)天,平均差0.2天(95%CI -0.1至0.4天)。
  • 停用组基线访视后抗生素使用比例为25.1%(52/207),继续组为90.1%(182/202),p 0.001。
  • 继续抗生素组不良事件相对风险为1.47(95%CI 0.80-2.71),后续3个月需进一步医疗接触的相对风险为0.61(95%CI 0.28-1.37)。

临床怎么用

  • 在基层医疗中,对已短期使用抗生素但医生判断不再需要的非复杂性呼吸道感染成人,可考虑停用抗生素。

局限性

  • 开放标签设计可能影响患者报告结局;有效分析样本409例,略低于随机总数467例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine the benefits and harms of discontinuing unnecessary antibiotic therapy for uncomplicated respiratory tract infections (RTI) when antibiotics are considered no longer necessary. METHODS: Multicentre, open-label, randomized controlled clinical trial in primary care centres from 2017 to 2020 (ClinicalTrials.gov, NCT02900820). Adults with RTIs-acute rhinosinusitis, sore throat, influenza or acute bronchitis-who had previously taken any dose of antibiotic for less than 3 days, which physicians no longer deemed necessary were recruited. The patients were randomly assigned in a 1:1 ratio to discontinuing antibiotic therapy or the usual strategy of continuing antibiotic treatment. The primary outcome was the duration of severe symptoms (number of days scoring 5 or 6 on a six-item Likert scale). Secondary outcomes included days with symptoms, moderate symptoms (scores of 3 or 4), antibiotics taken, adverse events, patient satisfaction and complications within the first 3 months. RESULTS: A total of 467 patients were randomized, out of which 409 were considered valid for the analysis. The mean (SD) duration of severe symptoms was 3.0 (1.5) days for the patients assigned to discontinuation and 2.8 (1.3) days for those allocated to the control group (mean difference 0.2 days; 95% CI -0.1 to 0.4 days). Patients randomized to the discontinuation group used fewer antibiotics after the baseline visit (52/207 (25.1%) versus 182/202 (90.1%); p 0.001). Patients assigned to antibiotic continuation presented a relative risk of adverse events of 1.47 (95% CI 0.80-2.71), but the need for further health-care contact in the following 3 months was slightly lower (RR 0.61; 95% CI 0.28-1.37). CONCLUSIONS: Discontinuing antibiotic treatment for uncomplicated RTIs when clinicians consider it unnecessary is safe and notably reduces antibiotic consumption.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Llor C, Moragas A, Bayona C, et al. Efficacy and safety of discontinuing antibiotic treatment for uncomplicated respiratory tract infections when deemed unnecessary. A multicentre, randomized clinical trial in primary care. Clin Microbiol Infect. 2021. PMID: 34363942. doi:10.1016/j.cmi.2021.07.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。